• Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
  • Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
  • Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
  • Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
  • Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
  • Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder

Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder

Powder: Yes
Customized: Non-Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Solid
Purity: >99%
Samples:
US$ 165/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory

Basic Info.

Model NO.
HNB-307
Transport Package
Aluminium Foil Bag, Cardboard Drum
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
5000kg/Month

Product Description

Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder

Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
Product name Pimecrolimus
Cas No. 137071-32-0
Molecular Formula C43H68ClNO11
Appearance White powder

Pimecrolimus is an immunophilin ligand, which binds specifically to the cytosolic receptor, immunophilin macrophilin-12.Target: OthersPimecrolimus blocks T-lymphocyte activation pathway by inhibiting calcineurin function. Pimecrolimus prevents the release of cytokines and pro-inflammatory mediators from mast cells. Pimecrolimus binds to macrophilin-12, the pimecrolimusmacrophilin complex then binds to the cytosolic enzyme calcineurin phosphatase. The pimecrolimus-macrophilin complex prevents the dephosphorylation of the cytoplasmic component of the nuclear factor of activated T cells by inhibiting the action of calcineurin. Pimecrolimus inhibits not only the transcription and synthesis of cytokines from mast cells, but also the release of preformed mediators serotonin and β-hexosaminidase by the inhibition of Fcε-RI-mediated degranulation and secretion.Pharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus PowderPharmaceutical Raw Material CAS 137071-32-0 Pimecrolimus Powder
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now